We and others have reported the role of drug-induced or ectopic RKIP expression in various cancer cell lines in the modulation of NF-κB signaling and its downstream targets that confer to the EMT phenotype and migratory and invasive properties of cancer cells [123,124,125,126,127,128]. This evidence concerns the gene NFKB1 and cancer.